催化剂性肉毒主义 (Iatrogenic botulism) 是一种致肉症
Guri Hagberg1, Emilie Ranheim Skytøen2, Ingvild Nakstad1
1Seksjon for hjerneslag, Nevrologisk avdeling, Oslo universitetssykehus, Ullevål.
概括
在外国诊所注射肉毒毒素后,发生了严重的阳性肉毒症. 这个案例突出了与国际上进行的化品手术相关的风险.
科学领域:
- 神经学 神经学
- 毒理学 毒理学 毒理学
- 皮肤病学 皮肤病学
背景情况:
- 毒素注射被广泛用于化品和治疗目的.
- 阳性肉毒症虽然很少见,但是一种严重的潜在并发症.
- 确保患者安全需要遵守严格的协议,无论治疗地点如何.
研究的目的:
- 报告一种严重的阳性肉毒主义病例.
- 强调医疗旅游中的安全考虑的重要性.
- 讨论毒素引起的的临床表现和管理.
主要方法:
- 病例报告详细介绍患者的经验.
- 对临床症状和诊断发现的审查.
- 治疗干预措施和患者结果的描述.
主要成果:
- 患者在注射后出现了严重的肉毒主义症状.
- 需要迅速的医疗干预来管理呼吸系统的损害.
- 在接受支持性护理后,患者完全康复.
结论:
- 阳性肉毒症可能是肉毒毒素注射的结果,即使在非传统环境中进行注射.
- 对此类手术的医疗旅游具有固有的风险,需要对患者进行彻底的咨询.
- 警和及时管理对于治疗肉毒素治疗后的不良事件至关重要.
更多相关视频
相关概念视频
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
682
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
682
Anticholinesterase Agents: Poisoning and Treatment
856
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856
Skeletal Muscle Relaxants: Therapeutic Uses
486
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
486
Prevention of Further Absorption of Poison
821
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
821
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K


